Safety and Feasibility of Thoracic Malignancy Surgery During the COVID-19 Pandemic.

ABSTRACT:

Background

The coronavirus disease 2019 (COVID-19) pandemic has decreased surgical activity, particularly in the field of oncology, because of the suspicion of a higher risk of COVID-19-related severe events. This study aimed to investigate the feasibility and safety of thoracic cancer surgery in the most severely affected European and Canadian regions during the COVID-19 pandemic.

Methods

The study investigators prospectively collected data on surgical procedures for malignant thoracic diseases from January 1 to April 30, 2020. The study included patients from 6 high-volume thoracic surgery departments: Nancy and Strasbourg (France), Freiburg (Germany), Milan and Turin (Italy), and Montreal (Canada). The centers involved in this research are all located in the most severely

SUBMITTER: Seitlinger J 

PROVIDER: S-EPMC7834157 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature